When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me. 
By David Armstrong. Originally published May 8, 2025. This narration was originally produced by The New York Times for ProPublica. 
Support our journalism by donating at <a href="http://propublica.org/donate">propublica.org/donate</a>.

When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me. By David Armstrong. Originally published May 8, 2025. This narration was originally produced by The New York Times for ProPublica. Support our journalism by donating at propublica.org/donate.

When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me. 
By David Armstrong. Originally published May 8, 2025. This narration was originally produced by The New York Times for ProPublica. 
Support our journalism by donating at <a href="http://propublica.org/donate" rel="noopener noreferrer">propublica.org/donate</a>.

The Price of Remission

ProPublica’s best long-form investigations, narrated. ProPublica is an independent, nonprofit newsroom that produces investigative journalism with moral force. We dig deep into important issues, shining a light on abuses of power and betrayals of public trust — and we stick with those issues as long as it takes to hold power to account. On this podcast, you can listen to important new investigations alongside our most compelling journalism from the archives. Support our journalism by donating at propublica.org/donate.

Share The Price of Remission

Sign up to save your podcasts

The Price of Remission

The Price of Remission